SB
SBIO.SW Invesco NASDAQ Biotech UCITS ETF USD
- USD
No recent price
- Total assets
- 576M
- Expense ratio
- 0.40%
- Dividend yield
- 0.85%
- 1-year return
- +32.37%
- Holdings
- 1
- Since
- 2014
Fund data as reported by the issuer, updated Oct 28, 2026. Total assets are in the fund's base currency.
What does SBIO.SW invest in?
- Largest sector: Healthcare (100.0%)
Invesco NASDAQ Biotech UCITS ETF USD performance
Sharpe ratio 0.74- This year
- +23.58%
- 1 year
- +32.37%
- 3 years
- +24.65%
- 5 years
- +7.80%
Volatility 20.9% over 1 year and 19.7% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
SBIO.SW price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Invesco NASDAQ Biotech UCITS ETF USD top holdings
The holdings of Invesco NASDAQ Biotech UCITS ETF USD are not available yet.
SBIO.SW sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
Company size
Average market cap 26.6B- Mega cap0.6%
- Big cap25.2%
- Medium cap35.3%
- Small cap26.6%
- Micro cap12.2%
Invesco NASDAQ Biotech UCITS ETF USD fund profile
- Fund name
- Invesco NASDAQ Biotech UCITS ETF USD
- Ticker
- SBIO.SW
- Exchange
- SIX Swiss Exchange
- Issuer
- Invesco
- Index tracked
- -
- Category
- Healthcare Equity
- Inception date
- Nov 6, 2014
- Trading currency
- USD
- Expense ratio
- 0.40%